Cite
HARVARD Citation
Brown, M. et al. (2021). Onabotulinum toxin-A versus extended release tolterodine in the management of idiopathic overactive bladder in children: A pilot randomised controlled trial (OVERT trial). Journal of pediatric urology. 17 (1), pp. 77.e1-77.e12. [Online].